Wolverine Blend 10mg
LOT MOL-112
>99.50%
HPLC purity · meets spec
- Labeled
- 5mg / 5mg
- Measured
- 5.20mg / 5.10mg
- Identity
- BPC-157 · TB-500
- Tested
- Aug 7, 2026
4 assays passed · ISO/IEC 17025 accredited
View certificate
Wolverine Blend | 5ct Peptide Strips
$40.00
Regular price
$60.00
Sale price
$40.00
Skip to product information
Wolverine Blend | 5ct Peptide Strips
$40.00
Regular price
$60.00
Sale price
$40.00
Type
Bundle & save
Price
$40.00
For research use only. Not for human consumption. Compassionate curators of fine peptides.
BPC-157 / TB-500 · 500 mcg / 500 mcg per strip
Mollecule WOLVERINE Blend (BPC-157/TB-500) is crafted for researchers seeking one of the most recognized peptides in modern peptide science. This synthetic peptide continues to be a popular subject of investigation for its unique biological profile and widespread presence throughout scientific literature. Every Mollecule batch is manufactured to rigorous quality standards and is independently third-party tested to verify identity, purity, and consistency. Each batch is supported by a Certificate of Analysis (COA), giving researchers confidence in the integrity of every product.
Pack
5ct Peptide Strips: $40.00
Also available: Wolverine Blend | 5mg/5mg Peptide Vials
Strip protocol
Ready-to-use films. No reconstitution.
-
Keep sealed
Leave films in the foil pouch at room temperature, away from moisture.
-
Use dry hands
Peel one film when needed. It dissolves on liquid contact in 30 to 60 seconds.
-
Record the lot
Note the lot number in your lab records and pair it with the matching COA.
Related peptides
Third-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch’s certificate below.
Sources & References
Peer-reviewed research
-
NEW ENGLAND JOURNAL OF MEDICINE
Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial
View Source -
THE LANCET
GLP-3 (RT) for People with Type 2 Diabetes - A Phase 2 Trial
View Source -
NATURE MEDICINE
GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease
View Source -
LANCET DIABETES & ENDOCRINOLOGY
Effects of GLP-3 (RT) on Body Composition
View Source -
PUBMED CENTRAL
Triple Agonism Based Therapies for Obesity
View Source -
PUBMED CENTRAL
GLP-3 (RT) - A Game Changer in Obesity Pharmacotherapy
View Source -
PUBMED CENTRAL
Efficacy and Safety of GLP-3 (RT) - Systematic Review & Meta-Analysis
View Source -
NATURE CELL DISCOVERY
Structural Analysis of Incretin Receptor Agonists
View Source